CARLSMED
PublicCARLSMED is now publicly traded
The data on this page reflects CARLSMED's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Jul 22, 2025
Last Round
Series C
Extension
Feb 1, 2025
Total Funding Raised
$207.5M
Company Overview
Carlsmed is a healthcare technology company that develops spinal implant devices and medical systems aimed at enhancing surgical outcomes and reducing healthcare costs for spine surgery.
Sector
Medical Devices
Verticals
Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
AI Layer
Application
Keywords
CARLSMED Comparables
Compare CARLSMED with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nivalon Medical Technologies Inc. | 70% | |
| Captiva Spine | 58% | |
| Amotio Health | 46% |
CARLSMED Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jul 22, 2025 | ||||
| Series C Extension | Feb 1, 2025 | ||||
| Series C | Mar 18, 2024 | ||||
| Series B | Apr 19, 2022 | ||||
| Series A | Dec 16, 2020 | ||||
Seed | Jun 23, 2020 |
Key People
Founding team and executive leadership
CARLSMED Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Vertical Group | Series B, Series A |
| B Capital Group | Series C |
| Device of Tomorrow Capital | Seed |
| Cove Fund | Seed, Series B, Series A |
| U.S. Venture Partners | Series C Extension, Series B, Series A, Series C |
| BofA Securities | IPO |
| B Capital Group | Series B |
Recent news
Latest coverage and updates
- launchesOct 14, 2026
Carlsmed, Inc. launches its aprevo(R) Lumbar Bi-lateral Posterior System commercially in the United States at the North American Spine Society's 41st Annual Meeting in Texas on Oct 14th '26, enabling a direct posterior approach for personalized spine fusion.
- attends_eventOct 14, 2026
On Oct 14th '26, Carlsmed, Inc. announces the U.S. commercial launch of its aprevo(R) Lumbar Bi-lateral Posterior System at the North American Spine Society’s 41st Annual Meeting in Texas.
- hiresOct 1, 2026
Carlsmed, Inc. appoints Tony Jarc as Chief Product and AI Officer in California on Oct 1st '26
- hiresSep 28, 2026
Carlsmed, Inc. hired Rich as Chief Financial Officer on Sep 28th '26.
- hiresSep 28, 2026
Carlsmed, Inc. hired Richard Heppenstall as Chief Financial Officer on Sep 28th '26.
CARLSMED Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access